Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital
Open Access
- 29 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 56 (5) , 988-989
- https://doi.org/10.1093/jac/dki357
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infectionJournal of Antimicrobial Chemotherapy, 2005
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- Metronidazole for Clostridium difficile-Associated Disease: Is It Okay for Mom?Clinical Infectious Diseases, 2005
- Reassessment of Clostridium difficile Susceptibility to Metronidazole and VancomycinAntimicrobial Agents and Chemotherapy, 2002
- Reduced susceptibility ofClostridium difficileto metronidazoleJournal of Antimicrobial Chemotherapy, 2001
- Molecular epidemiology of endemic Clostridium difficile infectionEpidemiology and Infection, 2001
- Antimicrobial Susceptibilities and Serogroups of Clinical Strains of Clostridium difficile Isolated in France in 1991 and 1997Antimicrobial Agents and Chemotherapy, 1999
- Metronidazole Susceptibility in Clostridium difficile Isolates Recovered from Cases of C. difficile -associated Disease Treatment Failures and SuccessesAnaerobe, 1999
- Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and EtestDiagnostic Microbiology and Infectious Disease, 1999